PortalPublikationenReboxetine for acute treatment of major depression: systemat...

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

Standard

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. / Eyding, Dirk; Lelgemann, Monika; Grouven, Ulrich; Härter, Martin; Kromp, Mandy; Kaiser, Thomas; Kerekes, Michaela F; Gerken, Martin; Wieseler, Beate.

in: BMJ-BRIT MED J, Jahrgang 341, 2010, S. 4737.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Eyding, D, Lelgemann, M, Grouven, U, Härter, M, Kromp, M, Kaiser, T, Kerekes, MF, Gerken, M & Wieseler, B 2010, 'Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.', BMJ-BRIT MED J, Jg. 341, S. 4737. <http://www.ncbi.nlm.nih.gov/pubmed/20940209?dopt=Citation>

APA

Eyding, D., Lelgemann, M., Grouven, U., Härter, M., Kromp, M., Kaiser, T., Kerekes, M. F., Gerken, M., & Wieseler, B. (2010). Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ-BRIT MED J, 341, 4737. http://www.ncbi.nlm.nih.gov/pubmed/20940209?dopt=Citation

Vancouver

Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ-BRIT MED J. 2010;341:4737.

Bibtex

@article{c221659b436945ad978d19bfda22f2ed,
title = "Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.",
abstract = "To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine.",
author = "Dirk Eyding and Monika Lelgemann and Ulrich Grouven and Martin H{\"a}rter and Mandy Kromp and Thomas Kaiser and Kerekes, {Michaela F} and Martin Gerken and Beate Wieseler",
year = "2010",
language = "Deutsch",
volume = "341",
pages = "4737",
journal = "BMJ-BRIT MED J",
issn = "0959-535X",
publisher = "British Medical Association",

}

RIS

TY - JOUR

T1 - Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

AU - Eyding, Dirk

AU - Lelgemann, Monika

AU - Grouven, Ulrich

AU - Härter, Martin

AU - Kromp, Mandy

AU - Kaiser, Thomas

AU - Kerekes, Michaela F

AU - Gerken, Martin

AU - Wieseler, Beate

PY - 2010

Y1 - 2010

N2 - To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine.

AB - To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine.

M3 - SCORING: Zeitschriftenaufsatz

VL - 341

SP - 4737

JO - BMJ-BRIT MED J

JF - BMJ-BRIT MED J

SN - 0959-535X

ER -